Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1980 Jun;77(6):3659–3663. doi: 10.1073/pnas.77.6.3659

Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion

T J Slaga 1, S M Fischer 1, K Nelson 1, G L Gleason 1
PMCID: PMC349677  PMID: 6774342

Abstract

The effects of nonpromoting and weakly promoting diterpenes on skin tumor promotion by 12-O-tetradecanoylphorbol 13-acetate (TPA) were investigated. When phorbol and phorbol 12,13-diacetate (both nonpromoting) were given simultaneously with TPA after 7,12-dimethylbenz[a]-anthracene (DMBA) initiation in female mice, they had no effect on TPA promotion. However, the nonpromoter 4-O-methyl-TPA and the weak promoter mezerein were found to inhibit TPA promotion in a dose-dependent manner when given simultaneously with TPA. Because mezerein was found to be an effective inhibitor of TPA promotion when given simultaneously and because it induces many biological responses similar to those to TPA, the capacity of mezerein to act as an incomplete promoter in a two-stage promotion protocol was also investigated. Twice-weekly applications of 1,2, or 5 μg of TPA for 2 weeks after DMBA initiation produced 0, 0, and 0.5 papilloma per mouse, respectively, at 20 weeks. When the twice-weekly applications of TPA for 2 weeks were followed by twice-weekly treatments with 2 μg of mezerein for 18 weeks, the number of papillomas per mouse was 2.2, 3.5, and 9.0, respectively. Twice-weekly applications of 2 μg of TPA for 2 weeks followed by twice-weekly treatments with 1, 2, or 4 μg of mezerein for 18 weeks produced 2.1, 3.5, and 6.8 papillomas per mouse, respectively, in DMBA-treated mice. Twice-weekly doses as high as 40 μg of 4-O-methyl-TPA were not effective in producing tumors when given after a limited treatment with TPA; however, 4-O-methyl-TPA had weak activity as a first-stage promoter. The results suggest that although mezerein by itself is a weak promoter and mimics TPA in many biochemical and morphological effects it is a potent second-stage promoter in a two-stage promotion regimen.

Keywords: carcinogenesis, phorbol esters

Full text

PDF
3659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOUTWELL R. K. SOME BIOLOGICAL ASPECTS OF SKIN CARCINOGENISIS. Prog Exp Tumor Res. 1964;4:207–250. doi: 10.1159/000385978. [DOI] [PubMed] [Google Scholar]
  2. Baird W. M., Sedgwick J. A., Boutwell R. K. Effects of phorbol and four diesters of phorbol on the incorporation of tritiated precursors into DNA, RNA, and protein in mouse epidermis. Cancer Res. 1971 Oct;31(10):1434–1439. [PubMed] [Google Scholar]
  3. Balmain A. The synthesis of specific proteins in adult mouse epidermis during phases of proliferation and differentiation induced by the tumor promoter TPA, and in basal and differentiating layers of neonatal mouse epidermis. J Invest Dermatol. 1976 Aug;67(2):246–253. doi: 10.1111/1523-1747.ep12513451. [DOI] [PubMed] [Google Scholar]
  4. Blumberg P. M., Driedger P. E., Rossow P. W. Effect of a phorbol ester on a transformation-sensitive surface protein of chick fibroblasts. Nature. 1976 Dec 2;264(5585):446–447. doi: 10.1038/264446a0. [DOI] [PubMed] [Google Scholar]
  5. Brown K. D., Dicker P., Rozengurt E. Inhibition of epidermal growth factor binding to surface receptors by tumor promotors. Biochem Biophys Res Commun. 1979 Feb 28;86(4):1037–1043. doi: 10.1016/0006-291x(79)90221-3. [DOI] [PubMed] [Google Scholar]
  6. Cohen R., Pacifici M., Rubinstein N., Biehl J., Holtzer H. Effect of a tumour promoter on myogenesis. Nature. 1977 Apr 7;266(5602):538–540. doi: 10.1038/266538a0. [DOI] [PubMed] [Google Scholar]
  7. Colburn N. H., Lau S., Head R. Decrease of epidermal histidase activity by tumor-promoting phorbol esters. Cancer Res. 1975 Nov;35(11 Pt 1):3154–3159. [PubMed] [Google Scholar]
  8. Driedger P. E., Blumberg P. M. Quantitative correlation between in vitro and in vivo activities of phorbol esters. Cancer Res. 1979 Mar;39(3):714–719. [PubMed] [Google Scholar]
  9. Fisher P. B., Goldstein N. I., Weinstein I. B. Phenotypic properties and tumor promotor-induced alterations in rat embryo cells transformed by adenovirus. Cancer Res. 1979 Aug;39(8):3051–3057. [PubMed] [Google Scholar]
  10. Huberman E., Callaham M. F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1293–1297. doi: 10.1073/pnas.76.3.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huberman E., Heckman C., Langenbach R. Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide. Cancer Res. 1979 Jul;39(7 Pt 1):2618–2624. [PubMed] [Google Scholar]
  12. Ishii D. N., Fibach E., Yamasaki H., Weinstein I. B. Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells. Science. 1978 May 5;200(4341):556–559. doi: 10.1126/science.644318. [DOI] [PubMed] [Google Scholar]
  13. Lee L. S., Weinstein I. B. Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors. Science. 1978 Oct 20;202(4365):313–315. doi: 10.1126/science.308698. [DOI] [PubMed] [Google Scholar]
  14. Mondal S., Brankow D. W., Heidelberger C. Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells. Cancer Res. 1976 Jul;36(7 Pt 1):2254–2260. [PubMed] [Google Scholar]
  15. Mondal S., Heidelberger C. Inhibition of induced differentiation of C3H/10T 1/2 clone 8 mouse embryo cells by tumor promoters. Cancer Res. 1980 Feb;40(2):334–338. [PubMed] [Google Scholar]
  16. Mondal S., Heidelberger C. Transformation of C3H/10T1/2CL8 mouse embryo fibroblasts by ultraviolet irradiation and a phorbol ester. Nature. 1976 Apr 22;260(5553):710–711. doi: 10.1038/260710a0. [DOI] [PubMed] [Google Scholar]
  17. Mufson R. A., Fischer S. M., Verma A. K., Gleason G. L., Slaga T. J., Boutwell R. K. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo. Cancer Res. 1979 Dec;39(12):4791–4795. [PubMed] [Google Scholar]
  18. Mufson R. A., Simsiman R. C., Boutwell R. K. The effect of the phorbol ester tumor promoters on the basal and catecholamine-stimulated levels of cyclic adenosine 3':5'-monophosphate in mouse skin and epidermis in vivo. Cancer Res. 1977 Mar;37(3):665–669. [PubMed] [Google Scholar]
  19. O'Brien T. G., Simsiman R. C., Boutwell R. K. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res. 1975 Jul;35(7):1662–1670. [PubMed] [Google Scholar]
  20. Pacifici M., Holtzer H. Effects of a tumor-promoting agent on chondrogenesis. Am J Anat. 1977 Sep;150(1):207–212. doi: 10.1002/aja.1001500116. [DOI] [PubMed] [Google Scholar]
  21. Raick A. N., Burdzy K. Ultrastructural and biochemical changes induced in mouse epidermis by a hyperplastic agent, ethylphenylpropiolate. Cancer Res. 1973 Oct;33(10):2221–2230. [PubMed] [Google Scholar]
  22. Raick A. N. Cell differentiation and tumor-promoting action in skin carcinogenesis. Cancer Res. 1974 Nov;34(11):2915–2925. [PubMed] [Google Scholar]
  23. Raick A. N. Cell proliferation and promoting action in skin carcinogenesis. Cancer Res. 1974 May;34(5):920–926. [PubMed] [Google Scholar]
  24. Raick A. N. Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoyl-phorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res. 1973 Feb;33(2):269–286. [PubMed] [Google Scholar]
  25. Raineri R., Simsiman R. C., Boutwell R. K. Stimulation of the phosphorylation of mouse epidermal histones by tumor-promoting agents. Cancer Res. 1973 Jan;33(1):134–139. [PubMed] [Google Scholar]
  26. Raineri R., Simsiman R. C., Boutwell R. K. Stimulation of the synthesis of mouse epidermal histones by tumor-promoting agents. Cancer Res. 1977 Dec;37(12):4584–4589. [PubMed] [Google Scholar]
  27. Rohrschneider L. R., O'Brien D. H., Boutwell R. K. The stimulation of phospholipid metabolism in mouse skin following phorbol ester treatment. Biochim Biophys Acta. 1972 Sep 7;280(1):57–70. doi: 10.1016/0005-2760(72)90212-3. [DOI] [PubMed] [Google Scholar]
  28. Shoyab M., De Larco J. E., Todaro G. J. Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors. Nature. 1979 May 31;279(5712):387–391. doi: 10.1038/279387a0. [DOI] [PubMed] [Google Scholar]
  29. Slaga T. J., Bowden G. T., Boutwell R. K. Acetic acid, a potent stimulator of mouse epidermal macromolecular synthesis and hyperplasia but with weak tumor-promoting ability. J Natl Cancer Inst. 1975 Oct;55(4):983–987. doi: 10.1093/jnci/55.4.983. [DOI] [PubMed] [Google Scholar]
  30. Slaga T. J., Scribner J. D., Rice J. M., Das S. B., Thompson S. Inhibition by dexamethasone of intracellular binding of phorbol esters to mouse skin. J Natl Cancer Inst. 1974 May;52(5):1611–1618. doi: 10.1093/jnci/52.5.1611. [DOI] [PubMed] [Google Scholar]
  31. Yamamoto N., zur Hausen H. Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature. 1979 Jul 19;280(5719):244–245. doi: 10.1038/280244a0. [DOI] [PubMed] [Google Scholar]
  32. Yuspa S. H., Lichti U., Ben T., Patterson E., Hennings H., Slaga T. J., Colburn N., Kelsey W. Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature. 1976 Jul 29;262(5567):402–404. doi: 10.1038/262402a0. [DOI] [PubMed] [Google Scholar]
  33. zur Hausen H., Bornkamm G. W., Schmidt R., Hecker E. Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc Natl Acad Sci U S A. 1979 Feb;76(2):782–785. doi: 10.1073/pnas.76.2.782. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES